Patent details

Basic Information

Publication number:

EP3825307

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP202037040

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN

French Title of Invention:

PROCÉDÉS DE SYNTHÈSE DE DEXTROMÉTHORPHANE DEUTÉRÉ

German Title of Invention:

VERFAHREN ZUR SYNTHESE VON DEUTERIERTEM DEXTROMETHORPHAN

SPC Number:

Dates

Filing date:

03/07/2017

Grant date:

03/08/2022

EP Publication Date:

26/05/2021

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

03/08/2022

EP B1 Publication Date:

03/08/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

03/07/2023

Expiration date:

03/07/2037

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/07/2022

 

 

Name:

Avanir Pharmaceuticals, Inc.

Address:

30 Enterprise, Suite 200, Aliso Viejo, CA 92656, United States (US)

Inventor

1

Name:

MENG, Weihua

Address:

China (CN)

2

Name:

LU, Zhijun

Address:

China (CN)

3

Name:

LI, Yan

Address:

China (CN)

4

Name:

JOHNSON, Matt

Address:

United States (US)

5

Name:

ZHAO, Cunxiang

Address:

China (CN)

Priority

Priority Number:

PCT/CN2016/088414

Priority Date:

04/07/2016

Priority Country:

World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:

C07D 221/28; A61P 11/14;

Publication

European Patent Bulletin

Issue number:

202231

Publication date:

03/08/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages